Licorice (Glycyrrhiza glabra) is widely utilized across the globe as both a traditional herbal medicine and a common ingredient in various food products. Its applications span centuries, with a strong presence in traditional Chinese medicine for treating conditions such as coughs and gastrointestinal issues, as well as in Western medicine for its potential therapeutic benefits. However, understanding its pharmacological properties and establishing safe consumption guidelines is crucial, especially given its widespread use.

Licorice contains several active compounds, most notably glycyrrhizin (glycyrrhizic acid), which can be metabolized in the body to produce glycyrrhetinic acid and glycyrrhetic acid glucuronide. Glycyrrhetinic acid is known for its detoxifying properties, whereas glycyrrhetic acid glucuronide has corticosteroid-like effects, leading to a range of pharmacological actions. While glycyrrhizin has demonstrated anti-inflammatory and antiviral properties, excessive consumption can pose significant health risks. It is essential to balance its therapeutic benefits against potential adverse effects to ensure safe use.

Licorice’s broad spectrum of applications reflects its value in both traditional and modern medicine. In traditional Chinese medicine, it is often used to harmonize the properties of other herbs and enhance their efficacy. Modern research supports licorice’s therapeutic potential, with studies showing that moderate doses (2-10g) can be effective in treating various health conditions and maintaining symptom relief.

Licorice flavonoids, in particular, have been found to exert protective effects against gastric ulcers and gastritis induced by Helicobacter pylori. They can also help mitigate damage from nonsteroidal anti-inflammatory drugs (NSAIDs) and other chemical agents by modulating the levels of key small-molecule metabolites, such as arachidonic acid, histamine, sphingosine-1-phosphate (S1P), and tryptophan. This modulation supports anti-inflammatory actions and enhances the defensive factors of the gastric mucosa.

While licorice has promising benefits, safety concerns must be carefully considered, particularly when consumed at high doses or over extended periods. Excessive glycyrrhizin intake can lead to sodium and water retention, hypokalaemia (potassium loss), and elevated blood pressure, which may result in symptoms akin to pseudoaldosteronism. These effects are especially concerning for individuals with pre-existing conditions such as hypertension, heart disease, diabetes, and other chronic illnesses.

Pregnancy and the postnatal period present additional risks; systematic reviews have indicated that high doses of licorice may increase the likelihood of adverse reactions. However, conclusive evidence is still lacking to establish whether licorice-containing herbal medicines should be restricted during pregnancy and postpartum. Nevertheless, prudence is warranted when recommending or consuming licorice during these periods.

To mitigate risks, it is vital that licorice consumption, particularly in patients with chronic conditions or those who are pregnant, be managed carefully and under professional supervision. The integration of traditional Chinese herbal treatments into Western medicine requires practitioners to exercise caution, taking into account the patient’s individual profile and health history. Pharmacovigilance measures, such as regular monitoring of patient responses, are essential to ensure the safety and effectiveness of licorice-based treatments.

In conclusion, licorice (Glycyrrhiza glabra) offers significant therapeutic potential when used appropriately, but careful consideration must be given to dosage, duration of use, and patient-specific factors. Healthcare providers should balance the benefits of licorice with the potential risks, particularly in individuals with pre-existing conditions, and employ monitoring practices to safeguard patient health. With thoughtful integration and professional oversight, licorice can be a valuable part of treatment plans that combine traditional and modern medical approaches.

Reference

1. Takahashi K, Yoshino T, Maki Y, et al. Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism: a multi-centre cross-sectional study. Arch Toxicol.2019, 93:3111–3119.
2. Yu JJ, Zhang SC, Coyle ME, et.al. Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials. Current Medical Research and Opinion. 2016,33(2):279-287
3. Penninkilampi R, Eslick EM, EslickGD.The association between consistent licorice ingestion, hypertension and hypokalemia: a systematic review and meta-analysis. Journal of Human Hypertension. 2017: 1–9.
4. Luís Â, Domingues F, Pereira L. Metabolic changes after licorice consumption: A systematic review with meta-analysis and trial sequential analysis of clinical trials. Phytomedicine. 2018,39:17-24.
5. Monder C, Stewart PM, Lakshmi P, et.al. Licorice Inhibits Corticosteroid 11B-Dehydrogenase of Rat Kidney and Liver: In Vivo and in Vitro Studies. Endocrinology. 1989,125(2):1046-1053.
6. Thakur V, Nargis S, Gonzalez M, et.al. Role of Glycyrrhizin in the Reduction of Inflammation in Diabetic Kidney Disease. Nephron. 2017,137(2):137-147.
7. Kageyama Y, Suzuki H, Saruta T. Glycyrrhizin induces mineralocorticoid activity through alterations in cortisol metabolism in the human kidney. Journal of Endocrinology. 1992,135:147-152.
8. Al-Qarawi AA, Abdel-Rahman HA, Ali BH, et.al. Liquorice (Glycyrrhiza glabra) and the adrenal-kidney-pituitary axis in rats. Food Chem Toxicol. 2002, 40(10):1525-7.
9. Nazari S, Rameshrad M, Hosseinzadeh H. Toxicological Effects of Glycyrrhiza glabra (Licorice): A Review. Phytother Res. 2017,31(11):1635-1650.
10. Kwon YJ, Son DH, Chung TH, et.al. A Review of the Pharmacological Efficacy and Safety of Licorice Root from Corroborative Clinical Trial Findings. J Med Food. 2020, 23(1):12-20.
11. 韦资源. 中药甘草及其制剂的配伍禁忌和禁忌症研究. 临床医药文献杂志. 2024,1(4):568.
12. 韩忠然. 中西药联合用的禁忌问题. 中国医药指南. 2008,6(17):96-97.
13. 李红旭, 唐国良. 甘草三参汤联合西药治疗早搏患者临床观察. 新中医. 2014,46(12):35-36.
14. 陈丽华. 甘草三参汤联合西药治疗心律失常的临床观察. 中国中医急症. 2014, 23(9):1694-1695.
15. 李光明. 甘草三参汤与西药用于心律失常治疗中的临床效果. 世界最新医学信息文摘. 2018,18(65):168+172.
16. Liew ZH, Lee KG. Liquorice-induced severe hypokalemic rhabdomyolysis with acute kidney injury. Ann Acad Med Singapore. 2017,46(9):354-355.
17. Pastorino G, Cornara L, Soares S, et.al. Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review. Phytother Res. 2018,32(12):2323-2339.
18. 徐硕, 徐文峰, 金鹏飞, 等. 甘草对药物代谢酶以及化学药物体内代谢的影响. 中南药学. 2017,15(03):329-334.
19. 王世华. 甘草炮制方法对甘草苷和甘草酸含量的影响. 中国医院用药评价与分析.2017,17(06):801-802+805.
20. 蔡永敏, 孙大鹏, 邹杰. 论甘草应分生甘草与炙甘草. 中国中医基础医学杂志. 2010,16(12):1164-1166.
21. 范子龙, 王淑华. 甘草与西药的不合理联用.中医药学报.1997(03):34.
22. 毕明义. 重剂甘草心汤治疗急性胃肠炎60例. 山东中医杂志. 1986(03):14.
23. 周文兰. 甘草泻心汤治疗复发性口腔溃疡的临床观察. 西南国防医药. 2004(06):635-636.
24. 于鲁志. 中药甘草抗炎作用药理和临床研究进展. 光明中医. 2017,32(19):2895-2898.
25. 彭思菡.甘草与西药配伍有宜忌. 河北中医. 2006(09):675-676.
26. 刘斌, 付正涛. 甘草与西药的配伍. 山西医药杂志. 2006(07):615-616.
27. 梁翠玲. 甘草口服溶液止咳平喘祛痰功效的临床实验研究. 亚太传统医药.2011,7(12):68-69.
28. 张志荣, 李书香. 大剂量服用甘草引起血压升高与下肢水肿1例. 河北医药. 2004(01):58.
29. Izzo AA, Di Carlo G, Borrelli F, et.al. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol. 2005,98(1):1-14.
30. Bernardi M, D’Intino PE, Trevisani F, et.al. Effects of prolonged ingestion of graded doses of licorice by healthy volunteers. Life Sci. 1994,55(11):863-72.
31. Yang Y, Wang S, Bao Y. et.al. Anti-ulcer effect and potential mechanism of licoflavone by regulating inflammation mediators and amino acid metabolism. Journal of Ethnopharmacology. 2017,199:175–182.
32. Jalilzadeh-Amin G, Najarnezhad V, Anassori E, et.al. Antiulcer properties of Glycyrrhiza glabra L. extract on experimental models of gastric ulcer in mice. Iranian Journal of Pharmaceutical Research. 2015,14(4):1163–1170.
33. Choi YH, Kim YJ, Chae HS, et.al. In Vivo gastroprotective effect along with pharmacokinetics, tissue distribution and metabolism of isoliquiritigenin in mice. Planta Medica. 2015, 81(7):586–593.
34. Liu J, Zhang H,  Xu L. Licorice and pregnancy: Does it cause harm? Journal of Maternal-Fetal & Neonatal Medicine. 2014,27(1):1-6.
35. Wang J, Sun M, Zhang Y. Impact of low-dose licorice consumption on pregnancy outcomes. Clinical Pharmacology & Therapeutics. 2018,104(3):453-459.

Click to download PowerPoint